Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).
Clinical trial NCT03713190 · COMPLETED
Trial details
- NCT number
- NCT03713190
- Sponsor
- University of Pisa
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2020-02-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.